Prediction of Malignant Hyperthermia Susceptibility in Low-risk Subjects An Epidemiologic Investigation of Caffeine Halothane Contracture Responses

The North American Malignant Hyperthermia Registry^¶

^¶The North American Malignant Hyperthermia Registry: Cleveland Clinic (Hiroshi Mitsumoto, M.D.; Glenn E. DeBoer, M.D.); Hahnemann University (Jeffrey E. Fletcher, Ph.D.; Henry Rosenberg, M.D.); Mayo Clinic (Denise J. Wedel, M.D.); Ottawa Civic Hospital (Gregory Allen, M.D., F.R.C.P.C.); Presbyterian University Hospital (Marshall Millman M.D., Ph.D.); Toronto General Hospital (Beverley A. Britt, M.D., F.R.C.P.C.); Uniformed Services University of Health Sciences (Sheila M. Muldoon, M.D.); University of California at Davis (Gerald A. Gronert, M.D.); University of California at Los Angeles (Jordan D. Miller, M.D.); University of Manitoba (Deepak D. Bose, M.D., Ph.D.; Leena R. Patel, M.D., F.R.C.P.C.); University of Massachusetts Medical Center (Barbara E. Waud, M.D.); University of Nebraska (Dennis F. Landers, M.D., Ph.D.); University of South Florida (Richard F. Kaplan, M.D.); University of Texas Health Science Center (Thomas E. Nelson, Ph.D.); University of Washington (Judy Y. Su, Ph.D.; Lawrence E. Jacobson, M.D.); University of Wisconsin (John F. Kreul, M.D.). Registry Site: Pennsylvania State University College of Medicine; Chairman: Gerald A. Gronert, M.D.; Secretary-Treasurer: Thomas E. Nelson, Ph.D.; Director: Marilyn Green Larach, M.D.